Breast Cancer Canada Shares Key Updates from the 2024 ESMO Congress in Barcelona

The 2024 ESMO Congress has highlighted significant advances in breast cancer research, aligning with Breast Cancer Canada’s mission to improve patient outcomes. Here are key findings from the congress that could shape the future of breast cancer treatment. NATALEE Trial: A Step Forward in Early HR+ Breast Cancer Treatment One of the major highlights is the […]